Drug Efficacy Publications
| Visscher H, Amstutz U, Sistonen J, Ross CJD, Hayden MR, Carleton B. Pharmacogenomics of cardiovascular drugs and effects in pediatrics. J Cardiovasc Pharmacol 2011 Sep;58(3):228-39. PMID: 21386709 | |
| Rogovik AL, Carleton B, Solimano A, Goldman R. Palivizumab for the prevention of respiratory syncytial virus infection. Can Fam Physician 2010 Aug:56(8):769-772. PMID: 20705882 | |
| Prosser R, Carleton BC, Smith MA. The comorbidity burden of the treated asthma patient population in British Columbia. Chronic Dis Can 2010 March;30(2): 46-55. PMID: 20302685 | |
| Zhang T, Carleton BC, Prosser RJ, Smith MA. The Added Burden of Comorbidity in Patients with Asthma. J Asthma 2009 Dec; 46(10):1021-6. PMID: 19995140 | |
| Jamieson B, Jain R, Carleton B, Goldman R. Use of oseltamivir in children. Can Fam Physician 2009 Dec;55(12):1199-1201. PMID: 20008597 | |
| Visscher H, Ross CJD, Dubé M-P, Brown AMK, Phillips, MS, Carleton BC, Hayden MR. Application of principal component analysis to pharmacogenomic studies in Canada. Pharmacogenomics J 2009 Dec; 9(6): 362-372. PMID: 19652663 | |
| Prosser RJ, Carleton BC, Smith MA. Identifying persons with treated asthma using administrative data via latent class modeling. Health Serv Res 2008;43(2):733-54. PMID: 18370976 | |
| Mitchell B., Carleton B.C., Smith M.A., Prosser B., Brownell M., Kozyrskyj A. Trends in psychostimulant and antidepressant use by children in two Canadian provinces. Can J Psychiatry 2008;53(3):152-9. PMID: 18441661 | |
| Ross CJD, Katzov H, Carleton B, Hayden MR. Pharmacogenomics and its implications for autoimmune disease. J Autoimmun 2007 Mar-May;28(2-3):122-8. PMID: 17418528 | |
Innovative Research Leading to Optimal Outcomes
